INFUSOR
Report
- Report Number
- 6000001-2011-22549
- Event Type
- Malfunction
- Date Received
- September 2, 2011
- Date of Event
- August 1, 2011
- Report Date
- August 12, 2011
- Manufacturer
- BAXTER HEALTHCARE - IRVINE
- Product Code
- MEB
- PMA / PMN Number
- K041738
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UT, US
- Reporter Occupation
- PHARMACIST
Narratives
(B)(4) ADDITIONAL INFORMATION: THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION. A LABELING REVIEW FOUND THE DIRECTIONS FOR USE: MIXING AND USE ADEQUATE FOR THE USE/USER ERROR IDENTIFIED IN THIS INCIDENT.
(B)(4). PER THE CUSTOMER, THIS DEVICE IS NOT AVAILABLE FOR EVALUATION. THEREFORE, THE REPORTED CONDITION COULD NOT BE CONFIRMED AND THE ROOT CAUSE COULD NOT BE DETERMINED. SHOULD THE DEVICE AND/OR ANY ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.
THE FACILITY REPORTED VIA PHONE THAT AN INFUSOR UNDERINFUSED DURING PATIENT USE. A VOLUME OF APPROXIMATELY 100 ML WAS INFUSED OVER THE COURSE OF 48 HOURS RATHER THAN 24 HOURS. THIS IMPLIES A 2.1 ML/HR FLOWRATE, WHICH IS 42% OF THE EXPECTED FLOWRATE. THE DEVICE WAS FILLED WITH A PRE-COMPOUNDED SOLUTION OF 0.1% ROPIVACAINE IN SALINE MANUFACTURED BY PHARMEDIUM. INFUSION FLOW RATE LESS THAN 70% OF EXPECTED RATE COULD LEAD TO A SERIOUS INJURY. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO PATIENT INJURY, MEDICAL INTERVENTION, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INFUSOR | PUMP, INFUSION, ELASTOMERIC | MEB | BAXTER HEALTHCARE - IRVINE | 11F018 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | ROPIVACAINE |